Therapy for inflammatory joint diseases, such as rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, includes various conventional disease-modifying antirheumatic drugs (DMARDs).

In two studies, no patients with rheumatoid arthritis using biological DMARDs ever had sustained DMARD-free remission. Sustained DMARD-free remission is more likely among those not requiring ...

There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...

For patients with rheumatoid arthritis and inadequate response to JAK inhibitors, cycling to another JAK inhibitor is a more ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

Methotrexate (MTX) has been used for rheumatoid arthritis (RA) treatment since 1980. It is the most common effective disease-modifying antirheumatic drug (DMARD) for RA, and is considered to be ...

If this medication doesn't work for you, your healthcare provider may switch to a biologic medication or add additional DMARDs to your treatment plan. Rheumatoid arthritis progression can vary ...

Rheumatoid arthritis (RA) is a chronic ... pharmacotherapy with one or more disease-modifying antirheumatic drugs (DMARDs), typically supported by non-steroidal anti-inflammatory drugs (NSAIDs ...

Rheumatoid arthritis (RA) is the most common type of ... early RA be treated with disease-modifying antirheumatic drugs (DMARDs). These medications help slow or stop RA from progressing and ...

For rheumatoid arthritis patients with inadequate response to JAK inhibitors, new research suggests cycling to another JAKi ...